麻豆传媒

UC Davis discovery demonstrates mechanism in dietary omega-3 fatty acids (fish oils)

News — A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and spread of the disease.

The scientists report their discovery in the Proceedings of the National Academy of Sciences (PNAS). The groundbreaking study was a collaboration among multiple UC Davis laboratories and Harvard University.

The metabolite is epoxy docosapentaenoic acid (EDP), an endogenous compound produced by the human body from the omega-3 fatty acid named docosahexaenoic acid (DHA), which is found in fish oil and breast milk. In animal studies, the UC Davis scientists found that EDP inhibits angiogenesis, the formation of new blood vessels in the body.

Tumors grow and spread by hijacking the normal biological process of angiogenesis, which plays a role in wound repair as well in growth and development. The UC Davis researchers determined that by inhibiting angiogenesis, EDP reduces the growth and spread (metastasis) of tumors in mice. The research provides the first scientific evidence about EDP鈥檚 potent anti-cancer, anti-metastatic effects.

EDP works by a different mechanism than many current anti-cancer drugs that block angiogenesis. 鈥淥ur investigation opens up a new understanding of the pathways by which omega-3 fatty acids exert their biologic effects,鈥� said Guodong Zhang, the lead author of the article and a postdoctoral researcher in the laboratory of Bruce Hammock in the Department of Entomology and the UC Davis Comprehensive Cancer Center.

The researchers said that future studies hopefully will determine that stabilized EDP can be safely and effectively combined with other current anti-angiogenesis drugs in the treatment of cancer.

鈥淎s far as we know, EDPs are the first signaling lipids that have been discovered to have such potent anti-cancer effects. Researchers may be able to use EDPs as structural targets to develop stable analogs as anti-cancer agents,鈥� Zhang said.

鈥淭he study by Zhang and colleagues has uncovered a previously unrecognized anti-cancer effect of omega-3 fatty acids, which are an important lipid component of diets that have been developed to prevent heart disease and cancer,鈥� said Jonathan R. Lindner, professor of medicine at Oregon Health & Sciences University.

鈥淭he authors have demonstrated that metabolites of these lipids can act to suppress the growth of new blood vessels that are necessary to feed tumor growth,鈥� added Lindner, who was not involved in the study. 鈥淏y shutting off a tumor鈥檚 blood supply, these compounds can act to dramatically slow tumor growth and prevent spread.聽 The results from this聽study suggest that new drug strategies for fighting cancer could emerge from knowledge of how the body uses聽nutrition to promote health.鈥�

The EDPs are broken down in the body by the enzyme soluble epoxide hydrolase (sEH). In previous research, Hammock鈥檚 lab showed that inhibitors of the sEH enzyme (sEHIs) help to normalize physiological activity. In the current study, UC Davis researchers determined that the addition of sEHI stabilized EDP in circulating blood thereby producing EDPs鈥� anti-tumor effects. The FDA-approved anti-cancer drugs sorafenib and regorafenib are also potent sEHIs.

鈥淚t may be possible to improve the efficacy of these anti-cancer drugs by combining them with a diet high in omega-3 and low in omega-6 fatty acids,鈥� Hammock said.

The researchers also found that a metabolite of arachidonic acid (ARA), an omega-6 fatty acid, has the opposite effect of EDP. The ARA metabolite, epoxyeicosatrienoic acids (EETs), slightly increases angiogenesis and tumor progression in mice.

鈥淭here is no free lunch,鈥� said Katherine W. Ferrara, professor in the UC Davis Department of Biomedical Engineering. 鈥淭he EETs encourage wound healing, while the EDPs block the growth and metastasis of solid tumors.

鈥淥ur results designate EDPs and EETs as unique mediators of an angiogenic switch to regulate tumorigenesis,鈥� Ferrara said. "They also implicate a novel mechanistic linkage between omega-3 and omega-6 fatty acids and cancers."

UC Davis scientists determined that EDP starves tumors by inhibiting vascular endothelial growth factor (VEGF) and fibroblast growth factor-2 (FGF-2)-induced angiogenesis in mice. In laboratory cultures, EDP also suppresses the endothelial cell migration needed for new blood vessels.

Thus, EDP-based angiogenesis inhibitors offer an advantage over angiogenesis inhibitors that target the VEGF-VEGFR2 pathway, which increase patients鈥� risk for developing high blood pressure.

Because EDPs widen the blood vessels, a medication based on the UC Davis researchers鈥� discovery should not increase the patient鈥檚 risk for high blood pressure.

Harvard researchers Mark Kieran and Dipak Panigrahy conducted the metastasis studies. The in vivo imaging work that allowed the scientists to monitor tumors in living mice was done in Ferrara鈥檚 UC Davis laboratory.

###

About the UC Davis Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center is the only National Cancer Institute comprehensive-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people.聽Its top specialists provide compassionate, comprehensive care for more than 9,000 adults and children every year, and offer patients access to more than 150 clinical trials at any given time. Its innovative research program includes more than 280 scientists at UC Davis and Lawrence Livermore National Laboratory.聽The unique partnership, the first between a major cancer center and national laboratory, has resulted in the discovery of new tools to diagnose and treat cancer. Through the Cancer Care Network, UC Davis is collaborating with a number of hospitals and clinical centers throughout the Central Valley and Northern California regions to offer the latest cancer-care services. Its community-based outreach and education programs address disparities in cancer outcomes across diverse populations. For more information, visit .